Repetitive Transcranial Magnetic Stimulation Plus Reactivation Therapy Efficacy on PTSD Symptom Severity in Resistant PTSD

Study acronym: TraumaStim
StatusUnknown
PhaseNot applicable
Started

Record status This record was last updated May 8, 2024 (before its estimated July 7, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Feb 2024 to Jul 7, 2026
    • Study completion date: Jul 2026 to Oct 7, 2026
    • Start date changed from estimate of Dec 2023 to Mar 7, 2024
    • Site details revised
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A French multicenter randomized and double blinded shamed controlled study recruiting patients who present resistant PTSD. The aim of this trial is to assess the efficacy of cerebral modulation by rTMS with simultaneous reactivation of traumatic memory on the PTSD symptoms at M1.
Trial Details
NCT Number NCT06111976
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions
(from sponsor)		 Post Traumatic Stress Disorder
Related terms Mental Disorders, Stress Disorders, Post-Traumatic, Stress Disorders, Traumatic
Enrollment 102 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov